Startup based in the United States, most recent round Acquired.
89bio is a company headquartered in the United States. 89bio has been acquired.
89bio is a clinical-stage biopharmaceutical company developing therapies focused on liver and cardiometabolic diseases, utilizing FGF21-based metabolic regulators.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.